Assertio Holdings, Inc. (NASDAQ:ASRT) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ET Company Participants Matt Kreps - Darrow Associates, Investor Relations Dan Peisert - President & Chief Executive Officer Paul Schwichtenberg - Senior Vice President & Chief Financial Officer Conference Call Participants Thomas Flaten - Lake Street Scott Henry - ROTH Capital Hamed Khorsand - BWS Financial Mitra Ramgopal - Sidoti Operator Good afternoon and welcome to the Assertio Holdings' Fourth Quarter and Full ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER 001-39294 ASSERTIO HOLDINGS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) Delaware 85-0598378 (STATE OR OTHER JURISDICTION OF (I ...

Assertio Holdings, Inc. Q4 2022 Financial Results -ASSERTIO= About This Presentation Statements in this communication that are not statements of historical fact are forward-looking statements that reflect Assertio's current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-39294 ASSERTIO HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 85-0598378 (STATE OR OTHER JURISDICTION OF (I.R.S ...

Spectrum Pharmaceuticals, Inc. (SPPI) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Michael Grabow - Executive Vice President of Chief Business Officer Thomas Riga - President and Chief Executive Officer Francois J. Lebel - Executive Vice President and Chief Medical Officer Nora Brennan - Executive Vice President and Chief Financial Officer Erin Miller - Senior Vice President Sales and Marketing Conference Call Participants Ed White - H.C. Wainwright Prakhar Agarwal - C ...

Spectrum Pharmaceuticals, Inc. (SPPI) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Michael Grabow - SVP, Corporate Strategy and Operations Thomas J. Riga - President and CEO Francois J. Lebel - EVP and CMO Nora E. Brennan - EVP and CFO Conference Call Participants Unidentified Analyst - Jefferies Ed White - H.C. Wainwright Reni Benjamin - JMP Securities William Wood - B. Riley Securities Prakhar Agarwal - Cantor Fitzgerald Operator Good day and thank you for standing by. ...

Spectrum Pharmaceuticals, Inc. (SPPI) Q1 2022 Results Conference Call May 12, 2022 4:30 PM ET Company Participants Michael Grabow - Senior Vice President of Corporate Strategy and Operations Thomas Riga - President and CEO Francois Lebel - Chief Medical Officer Conference Call Participants Maury Raycroft - Jefferies Edward White - H.C. Wainwright Mayank Mamtani - B. Riley Securities Operator Thank you for standing by. And welcome to the Spectrum Pharmaceuticals First Quarter 2022 Earnings Conference Call. A ...